Theratechnologies Inc. (THTX)

Theratechnologies Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Year Ending	TTM	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Net Income	-7	-23.96	-47.24	-31.73	-22.67	-12.5
Depreciation & Amortization	3.22	3.32	12.47	8.75	8.52	7.5
Share-Based Compensation	2.07	2.22	3.87	1.93	1.27	0.45
Other Operating Activities	0.93	12.75	16.2	3.54	-0.68	1.16
Operating Cash Flow	-0.78	-5.68	-14.69	-17.5	-13.55	-3.39
Capital Expenditures	-0.02	-0.32	-0.99	-0.13	-0.03	-1.22
Change in Investments	3.71	2.93	9.67	-12.57	4.41	2.29
Other Investing Activities	-3	-1.5	-	-0.04	0.4	-1.21
Investing Cash Flow	0.7	1.11	8.68	-12.74	4.78	-0.13
Share Issuance / Repurchase	-	23.58	2.89	43.95	0.15	0.11
Debt Issued / Paid	-8.63	-8.6	8.29	-5.64	-4.07	-3.5
Other Financing Activities	22.89	-0.2	-1.53	-0.45	-3.31	-3.42
Financing Cash Flow	14.27	14.78	9.66	37.86	-7.23	-6.81
Exchange Rate Effect	0.02	0.04	-0.19	0.04	0.08	-0.01
Net Cash Flow	14.19	10.21	3.65	7.63	-16.01	-10.33
Free Cash Flow	-0.79	-6	-15.68	-17.63	-13.59	-4.61
Free Cash Flow Margin	-0.96%	-7.33%	-19.58%	-25.25%	-20.57%	-7.29%
Free Cash Flow Per Share	-0.02	-0.25	-0.66	-0.74	-0.71	-0.30

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).